Porton Pharma Solutions Ltd. (SHE:300363)
China · Delayed Price · Currency is CNY 20.94
-0.89 (-4.08%)
Sep 10, 2026, 3:04 PM CST
Porton Pharma Solutions Market Cap
Porton Pharma Solutions has a market cap or net worth of 11.71 billion as of September 9, 2026. Its market cap has decreased by -15.98% in one year.
Market Cap
11.71B
Enterprise Value
11.97B
Revenue
3.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
20.94
ChartMarket Cap Chart
Since January 29, 2014, Porton Pharma Solutions's market cap has increased from 3.94B to 11.71B, an increase of 197.10%. That is a compound annual growth rate of 9.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 11.71B | -6.74% |
| Dec 31, 2025 | 12.55B | 45.94% |
| Dec 31, 2024 | 8.60B | -37.37% |
| Dec 29, 2023 | 13.73B | -38.42% |
| Dec 30, 2022 | 22.31B | -54.20% |
| Dec 31, 2021 | 48.70B | 145.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wedge Industrial | 11.51B |
| Shanghai Shyndec Pharmaceutical | 11.36B |
| Shenzhen Chipscreen Biosciences | 11.21B |
| Zhejiang CONBA Pharmaceutical | 11.09B |
| Henan Lingrui Pharmaceutical | 11.07B |
| Beijing Aosaikang Pharmaceutical | 11.05B |
| Yantai Dongcheng Pharmaceutical Group | 10.49B |
| Guangdong Taienkang Pharmaceutical | 10.19B |